US OptionsDetailed Quotes
TGTX250502C41500
- 4.05
- +1.60+65.31%
15min DelayClose Apr 30 16:00 ET
4.05High3.72Low
3.72Open2.45Pre Close5 Volume29 Open Interest41.50Strike Price1.89KTurnover0.00%IV0.09%PremiumMay 2, 2025Expiry Date4.01Intrinsic Value100Multiplier1DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma13.10Leverage Ratio--Theta--Rho--Eff Leverage--Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet